


Oxford BioDynamics Email Formats
Biotechnology Research • Oxford, England, United Kingdom • 51-100 Employees
Oxford BioDynamics Email Formats
Oxford BioDynamics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@oxfordbiodynamics.com), used 58.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@oxfordbiodynamics.com | 58.8% |
{first name}.{last name} | john.doe@oxfordbiodynamics.com | 35.3% |
{first initial}.{second initial} | j.o@oxfordbiodynamics.com | 5.9% |
Key Contacts at Oxford BioDynamics
Bartu Ahiska
Senior Director, Commercial Development
Phil Manley
Director Of Sales
David Blum
Senior Vice President, Head Of Sales & Marketing
Greer Jattan
Sr. Director, Clinical Sales And Market Access
Jayne Green
Director Of Operations
Rachelle Murphy
Market Development Director
Ellen Wambach
Clinical Customer Service, Director
Clint Barnett
Associate Director Of Raqa
Company overview
| Headquarters | 3140 Rowan Place, John Smith Drive, Oxford Business Park South, Oxford, Oxfordshire OX4 2WB, GB |
| Phone number | +442284653 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Diagnostics, Oncology, Age-Related Diseases, Auto-Immune Disorders, Biomarker Discovery & Development, Companion Diagnostics, Epigenetics, Neurodegenerative Diseases, Precision Medicine, Immuno-Oncology, Clinical Trial Design |
| Founded | 2007 |
| Employees | 51-100 |
| Socials |
About Oxford BioDynamics
Oxford BioDynamics (OBD) is a global biotech company advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. OBD aims to help people face the most challenging health decisions with confidence and tackle the rising costs of healthcare with a portfolio of clinical tests and research tools based on its proprietary EpiSwitch® technology, uniquely capable of reproducibly translating 3D genome regulation for clinical application. The company’s flagship product, EpiSwitch CiRT (Checkpoint inhibitor Response Test), is a first-of-its-kind smart blood test for cancer patients that provides guidance on navigating the toughest challenges of immunotherapy like treatment planning, pseudo-progression, and adverse events. The company is partnering with CLIA-certified commercial labs to deliver these important tests into the hands of physicians to meet demand and help patients as quickly as possible. OBD’s 24,000 sq ft headquarters in Oxford, UK, houses offices and state-of-the-art laboratory facilities. OBD’s commercial team has an office in Gaithersburg, MD, USA, and the company has an ISO-certified laboratory in Penang, Malaysia. OBD has participated in 40+ partnerships with pharma and leading institutions, including Pfizer, EMD Serono, Genentech, Roche, Biogen, Mayo Clinic, Massachusetts General Hospital, and Mitsubishi Tanabe Pharma. The Company has created a valuable technology portfolio, including biomarker arrays, molecular diagnostics, bioinformatic tools for 3D genomics, and an expertly curated 3D genome knowledgebase comprising hundreds of millions of data points from 10,000+ samples in 30+ human diseases. OBD’s proprietary EpiSwitch technology maps this 3D architecture at scale, identifying abnormal configurations that can be used to diagnose patients or predict how someone may respond to a disease or treatment. For more information, please visit oxfordbiodynamics.com.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Oxford BioDynamics has 23 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Oxford BioDynamics's funding history, including investment rounds, total capital raised, and key backers.
Oxford BioDynamics Tech Stack
Discover the technologies and tools that power Oxford BioDynamics's digital infrastructure, from frameworks to analytics platforms.
Cookie compliance
JavaScript libraries
Video players
Miscellaneous
Web servers
JavaScript libraries
Webmail
Security
Analytics
UI frameworks
Security
Frequently asked questions
4.8
40,000 users



